Besides, SFRP4 was an important Wnt signaling antagonist, and activation of SFRP4 could lead to Wnt signaling suppression and histone modification in PCa stem cells and thereby sensitized tumor cells to chemotherapeutic drugs, enhancing cell death (56). The gene discussed is SFRP4; the disease is posterior cortical atrophy.